J.P. Morgan Notebook Day 4: Novartis CEO Weighs In On AI, Sangamo’s Next Steps And More

 
• By Joseph Haas, Mandy Jackson, Jessica Merrill, and Andrew McConaghie

Additional highlights from the J.P. Morgan Healthcare Conference, including Takeda’s partnering outlook, Sage’s guidance on Zulresso sales, Frequency’s next steps for its hearing loss drug and Revance’s preparations to take on the aesthetics market. 

Golden Gate bridge with city in background, San Fransisco, CA
More updates as industry departs San Francisco

More from Strategy

More from Business